Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clinical Infectious Diseases 2021, 75: e1112-e1119. PMID: 34499124, PMCID: PMC8522427, DOI: 10.1093/cid/ciab779.Peer-Reviewed Original ResearchConceptsLiver-related deathPre-pandemic levelsHepatitis C outcomesCoronavirus disease 2019 (COVID-19) pandemicCOVID-19-related disruptionsPre-pandemic ratesDisease 2019 pandemicHCV careHCV outcomesVirologic responseHCV epidemicTreatment initiationPandemic-related disruptionsCare disruptionsC outcomesAdditional casesCare servicesCare deliveryCirrhosisHCVHealthcare deliveryCOVID-19COVID-19 pandemicAggressive effortsOutcomesProjected Estimates of Opioid Mortality After Community-Level Interventions
Linas BP, Savinkina A, Madushani RWMA, Wang J, Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Network Open 2021, 4: e2037259. PMID: 33587136, PMCID: PMC7885041, DOI: 10.1001/jamanetworkopen.2020.37259.Peer-Reviewed Original ResearchConceptsCommunity-level interventionsOverdose mortalityOpioid overdoseUse of MOUDDistribution of naloxoneOpioid overdose deathsDecision analytical modelOpioid overdose ratesMOUD retentionOUD populationOpioid mortalityMAIN OUTCOMEMOUDNaloxone distributionOverdose deathsOverdose ratesSingle interventionMortalityNaloxoneInterventionMonthsOverdoseProjected estimatesHuman ServicesOutcomes